Improving Methods for ChIP-seq | Biocompare: The Buyer's Guide for Life Scientists
Mapping Protein Binding Sites and Conformational Epitopes Using Cysteine Labeling and Yeast Surface Display
HER2-targeted dual radiotracer approach with clinical potential for noninvasive imaging of trastuzumab-resistance caused by epitope masking
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
Choosing your fixation embedding and antigen retrieval method for successful IHC - Enzo Life Sciences
Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies. - Abstract - Europe PMC
When CAR T cell therapy crashes
Surface-Epitope Masking (SEM) | SpringerLink
Design and development of masked therapeutic antibodies to limit off-target effects: Application to anti-EGFR antibodies
Surface-Epitope Masking (SEM) | SpringerLink
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts | Journal for ImmunoTherapy of Cancer
Mechanisms of resistance to trastuzumab: (1) epitope masking, such that... | Download Scientific Diagram
IL-7 Induces an Epitope Masking of γc Protein in IL-7 Receptor Signaling Complex
Surface-Epitope Masking (SEM) | SpringerLink
Masking terminal neo-epitopes of linear peptides through glycosylation favours immune responses towards core epitopes producing parental protein bound antibodies | Scientific Reports
Mapping epitopes and antigenicity by site-directed masking | PNAS
Epitope masking and glycan shield – The Veesler Lab
Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response - ScienceDirect
Frontiers | Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development | Journal of Translational Medicine | Full Text
Cells | Free Full-Text | CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity
